Krishnamurthy, A., Wang, H., Rhee, J. C., Davar, D., Moy, R. H., Ratner, L., Christner, S. M., Holleran, J. L., Deppas, J., Sclafani, C., Schmitz, J. C., Gore, S., Chu, E., Bakkenist, C. J., Beumer, J. H., & Villaruz, L. C. (2025). Phase I trial of ATR inhibitor elimusertib with FOLFIRI in advanced or metastatic gastrointestinal malignancies (ETCTN 10406). Cancer Chemotherapy and Pharmacology, 95(1). https://doi.org/10.1007/s00280-024-04745-6

Parte, S., Pothuraju, R., Kumavath, R., Bhatia, R., Nimmakayala, R. K., & Gautam, S. (2024). Editorial: Altered metabolic traits in gastrointestinal tract cancers. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1390877

Vujasinovic, M., Elbe, P., Ekheden, I., Wang, Q.-L., Thuresson, M., Roelstraete, B., Ghazi, S., Löhr, J.-M., & Ludvigsson, J. F. (2024). Gastrointestinal cancer precursor risk and mortality in pancreatic intraductal papillary mucinous neoplasms: a nationwide cohort study. Scandinavian Journal of Gastroenterology, 59(5), 600–607. https://doi.org/10.1080/00365521.2024.2310162

Zheng, B., Artin, M. G., Chung, H., Chen, B., Sun, S., May, B. L., Hur, C., Green, P. H. R., Wang, T. C., Park, J., & Kong, X. (2022). Immunogenetics of gastrointestinal cancers: A systematic review and retrospective survey of inborn errors of immunity in humans. Journal of Gastroenterology and Hepatology, 37(6), 973–982. Portico. https://doi.org/10.1111/jgh.15848